News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Gilberto Lopes: In phase 3 EVOKE-01 study improvement of OS was noted in patients without response to prior IO
Photo generated from meetings.asco.org
Jun 3, 2024, 13:08

Gilberto Lopes: In phase 3 EVOKE-01 study improvement of OS was noted in patients without response to prior IO

Gilberto Lopes, Chief of the Division of Medical Oncology at Sylvester Comprehensive Cancer Center, shared a post on X:

“LBA out: Phase 3 EVOKE-01 study. Sacituzumab vs Docetaxel… and… no better! Underwhelming results. One subgroup to note ‘Clinically meaningful improvement of OS was noted in patients without response to prior IO’. 383 patients OS 8.3 vs 11.8 for these patients HR 0.75 (0.58–0.97).”

Image

Read further
Source: Gilberto Lopes/X

2024 Annual Meeting of ASCO 3 EVOKE-01 ASCO24 cancer docetaxel Gilberto Lopes IO therapy LBA OncoDaily Oncology Sacituzumab
Special Coverage
Blog
Mar 31, 2025, 18:15
Beau Bosko Toskich: Clinical and Dosimetric Guidelines for Y-90 Glass Microsphere Radioembolization
Blog
Mar 31, 2025, 18:09
Ray Chan: Can’t wait for William Dale’s lecture this Thursday at Flinders University
Science
Mar 31, 2025, 18:00
Partha Basu: Guidance from IARC/WHO on validating HPV detection tests with lower valency
Blog
Mar 31, 2025, 17:58
Trends in Outpatient Opioid Prescriptions for Cancer Pain Between 2016 and 2021
Blog
Mar 31, 2025, 17:50
Lauren Averett Byers: Awesome clinic with Dr. Elyse Rose Lopez
Blog
Mar 31, 2025, 17:45
Lianne Mandelbaum: Flying with food allergies - Combating misconceptions and advocating for safety
Blog
Mar 31, 2025, 17:01
Navigating care: understanding cancer patients’ experiences with systemic radionuclide therapy - MASCC
Blog
Mar 31, 2025, 16:46
Join Dr. Nicola Normanno at ISMRC 2025 for insights on biomarker discovery and ctDNA testing
Career
Mar 31, 2025, 16:23
Karen Knudsen has been appointed as the CEO of the Parker Institute for Cancer Immunotherapy
Blog
Mar 31, 2025, 15:57
Register Today for the 2025 Breast Cancer Symposium
Blog
Mar 31, 2025, 15:45
Allison Betof Warner: Last Call for Abstracts to the 2025 SNO/ASCO CNS Metastasis Conference
Blog
Mar 31, 2025, 15:33
Luis Moreno Sánchez: Reirradiation in the Management of Locally Recurrent Rectal Adenocarcinoma